UCB - Ativo Circulante





Ativo Circulante Alterar Data
Alcon AG USD 6.62B 4M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Amarin USD 602.76M 23.26M 2026-06
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Genmab DKK 2.8B 228M 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
GRIFOLS EUR 5.31B 51M 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.77B 393M 2026-06
Novartis USD 27.35B 744M 2026-06
Orion EUR 1.2B 211.8M 2026-06
Recordati EUR 1.76B 29.78M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
UCB EUR 6.05B 733M 2025-12
Unibail Rodamco EUR 3.97B 1.09B 2025-12